PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
09-Nov-2020 OncoHost to Present Data on Predicting Host Response to Immunotherapy in Melanoma Patients at SITC 2020 OncoHost
09-Nov-2020 Registration is now open for SMi’s 15th Annual Parallel Trade Conference 2021 SMi Group Ltd
09-Nov-2020 HRA Pharma appoints OTC Medical as distributor in the Netherlands in a bid to expand further in the Dutch market HRA Pharma
09-Nov-2020 BioMed X Institute Announces Expansion of their Strategic Collaboration with Janssen in Immunology Research B3C newswire
09-Nov-2020 APEIRON Biologics AG and Domainex Ltd announce the expansion of their partnership to progress targeted cancer immune therapy drug discovery APEIRON Biologics AG
09-Nov-2020 APEIRON Biologics AG and Domainex Ltd announce the expansion of their partnership to progress targeted cancer immune therapy drug discovery Sciad Newswire
09-Nov-2020 Global Cardiomyopathy Devices Market 2020: Cleveland Clinic, Boston Scientific, Bionet, BTL Corporate SysGalaxy Market Research
09-Nov-2020 Global Cardiology Surgical and Interventional Cardiology Devices Market 2020: Abbott Cardiovascular, Biosense Webster Inc, Boston Scientific Corporation, C.R. Bard Inc SysGalaxy Market Research
09-Nov-2020 Formycon and Bioeq announce Launch of Phase III Study of FYB202, a Biosimilar Candidate for Stelara(R)* (Ustekinumab) Formycon AG
09-Nov-2020 Pharming appoints Jeroen Wakkerman as Chief Financial Officer Pharming Group N.V.
09-Nov-2020 Inmagene Biopharmaceuticals closed $21 million Series B financing, making the total raised to date over $40 million Inmagene Biopharmaceuticals
08-Nov-2020 Merck to Collaborate with Donghao Lansheng to Pilot New Import Policy in China Merck
07-Nov-2020 EIP Pharma Announces Presentation of Positive Clinical Trial Results with Neflamapimod at the 13th Clinical Trials in Alzheimer's Disease (CTAD) Meeting EIP Pharma, Inc.
07-Nov-2020 FDA Permits Marketing of New Device Designed to Reduce Sleep Disturbance Related to Nightmares in Certain Adults U.S. Food and Drug Administration
06-Nov-2020 Coronavirus (COVID-19) Update: FDA Authorizes First Test that Detects Neutralizing Antibodies from Recent or Prior SARS-CoV-2 Infection U.S. Food and Drug Administration
06-Nov-2020 Coronavirus (COVID-19) Update: FDA Authorizes First Test that Detects Neutralizing Antibodies from Recent or Prior SARS-CoV-2 Infection U.S. Food and Drug Administration
06-Nov-2020 FDA Takes Efforts to Protect Patients from Potentially Harmful Compounded Drugs Through Finalizing Insanitary Conditions Guidance U.S. Food and Drug Administration
06-Nov-2020 CVS Health Reports Third Quarter Results With Diversified Assets Delivering Strong Enterprise Performance CVS Health Corporation
06-Nov-2020 RHÖN-KLINIKUM Aktiengesellschaft - results for the first nine months 2020 RHÖN-KLINIKUM Aktiengesellschaft
05-Nov-2020 Formycon informs about the modified BLA-Submission Strategy for its Lucentis(R)* Biosimilar-Candidate FYB201 Formycon AG